4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017304
Director sold 20,000 shares at $57.80 ($1,156,000)
- Director acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pellini Michael J Director | 2021-03-01 | Option exercise | +20,000 | $6.55 | $131,000 | 20,000 | D: show line 1 in the form |
| Pellini Michael J Director | 2021-03-01 | Sale | −20,000 | $57.80 | $1,156,000 | 0 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $57.80 · $1,156,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pellini Michael J Director | 2021-03-01 | Option exercise · Stock Option (Right to Buy) | −20,000 | 55,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…